ENTRY       D12370                      Drug
NAME        Lutikizumab (INN)
FORMULA     C6454H9900N1694O2017S42
EXACT_MASS  144751.2449
MOL_WEIGHT  144840.5334
SEQUENCE    (Heavy chain)
            EVQLQESGPG LVKPSETLSL TCAVTGYSIT SGYSWHWIRQ FPGNGLEWMG YIHSSGSTNY
            NPSLKSRISI SRDTSKNQFF LKLSSVTAAD TAVYYCAGYD DYFEYWGQGT TVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PEAAGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASQNVG FNVAWYQQKP GKSPKALIYS ASYRYSGVPS
            RFSGSGSGTD FTLTISSLQP EDFAEYFCQQ YNWYPFTFGQ GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H143-H199, H219-L214, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'214, H'260-H'320, H'366-H'424, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
EFFICACY    Anti-inflammatory, Anti-interleukin 1alpha/ beta antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of osteoarthritis
TARGET      IL1 [HSA:3552 3553] [KO:K04383 K04519]
BRITE       Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D12370  Lutikizumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL1
                 D12370  Lutikizumab (INN)
DBLINKS     CAS: 1791411-57-8
///
